McPherson’s is continuing to diversify its business and this is expected to deliver earnings growth in the next few years, according to Moelis.
Moelis has taken a look at the portfolio of products waiting in the wings at Mayne Pharma and considers there is more upside for the stock.
Moelis has initiated coverage of little known technology designer, Altium, with a Buy rating.
Employment conditions are tough at present but Moelis examines one company seeing some light at the end of the tunnel in 2014.
Brokers look through small cap stocks and find the best stories in specialty retailers, industrials with dividend yields and low-cost base metal producers.
Moelis takes a look at Austin Engineering, which recently made an acquisition in Chile.
Microequities has exited a profitable position in Patties Foods given the risks of fighting against a duopoly based not on retailing prowess, but on government-sanctioned power.
Carbon capture and biofuel production pioneer Algae.Tec has signed a deal with NSW’ largest coal-fired power station to construct an adjacent capture/production facility, believed to be a wold-first for coal-related industry.
Austin Exploration is making progress in highly prospective areas of the Eagle Ford and Niobrara unconventional oil and gas regions.
REVA Medical has commenced recruiting for a CE Mark trial of its new stent product, which has Bell Potter assessing the potential of the stock.